Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
Authors
Keywords
Chronic myeloid leukemia, <em class=EmphasisTypeItalic >BCR</em>–<em class=EmphasisTypeItalic >ABL1</em>, Tyrosine kinase inhibitors, Hippo pathway, Aurora kinases
Journal
MEDICAL ONCOLOGY
Volume 35, Issue 3, Pages -
Publisher
Springer Nature
Online
2018-01-31
DOI
10.1007/s12032-018-1079-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways
- (2017) Nanda Kumar Sasi et al. NEOPLASIA
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy
- (2015) Aline Fernanda Ferreira et al. ACTA HAEMATOLOGICA
- TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells
- (2015) Tian Tian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hippo-YAP signaling pathway: A new paradigm for cancer therapy
- (2014) Yanlei Ma et al. INTERNATIONAL JOURNAL OF CANCER
- YAP1expression in myelodysplastic syndromes and acute leukemias
- (2014) João Agostinho Machado-Neto et al. LEUKEMIA & LYMPHOMA
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
- (2014) M Bartucci et al. ONCOGENE
- The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
- (2013) N Reuven et al. CELL DEATH AND DIFFERENTIATION
- MST1/2andYAP1gene expression in acute myeloid leukemia
- (2013) Shamsi Safari et al. LEUKEMIA & LYMPHOMA
- TAZ Expression as a Prognostic Indicator in Colorectal Cancer
- (2013) Hiu-Fung Yuen et al. PLoS One
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- The potential role of Aurora kinase inhibitors in haematological malignancies
- (2011) Sherif S. Farag BRITISH JOURNAL OF HAEMATOLOGY
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis
- (2011) Norikazu Yabuta et al. CELL CYCLE
- Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX
- (2011) D K Walters et al. LEUKEMIA
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
- (2009) Michele Baccarani et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Aurora B kinase in non-Hodgkin lymphoma
- (2009) Takayuki Ikezoe et al. LABORATORY INVESTIGATION
- Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
- (2009) S Boehrer et al. ONCOGENE
- MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
- (2008) Maria Praskova et al. CURRENT BIOLOGY
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started